The rich get richer?

Published 19-OCT-2015 16:49 P.M.


2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

The great divide between those with plenty of money and those without is getting wider, according to a report this year by the Organisation for Economic Co-operation and Development (OECD). So why are the rich getting richer?

According to the OECD report, the top 10% receive approximately nine times more than the bottom 10%, and the gap has been widening over the past 30 years. While the statistics don’t surprise me, why aren’t more people moving up?

I found the reason is largely due to how those outside of the top 10% think about money and building wealth, and how most fail to learn early in their working lives how to use money they don’t have to generate more.

A small percentage of Australians are comfortable with using leverage/debt to build wealth, and use it smartly, largely because they understand how it works. Those who don’t, follow a very different path. You may know people who shackle themselves to a big mortgage, which provides no tax benefit, just to put a roof over their heads.

In so doing, these Australians scrimp and save for most of their working lives, and only if there is anything left over do they invest. In my opinion, unless we change this, the gap between the ‘haves’ and the ‘have nots’ will only widen.

But let’s turn our attention to the markets.

Australian equities received a boost tecently, with the All Ordinaries Index closing strongly at 5309 points, well above the all-important 5200 point level. Last week news that Westpac will increase interest rates, and Chinese inflation data remains soft, threatened the continuation of the rise for Australian shares mid-week.

However, on Thursday the market returned to rise, supported by steady unemployment data and a potential low that appears to be forming for the Energy sector.

Looking to our biggest trading partners, my current view for Asian markets is similar to that of the XAO, in that lows are either already in or these markets are very close to a turn. I’m not suggesting that you need to watch Asian markets to make an assessment of the Australian market, however, a solid rise on Asian markets is likely to be followed by a further strong rise for Australian shares.

Dale Gillham is Chief Analyst at Wealth Within

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free